NewLink Genetics (NLNK) Tops Q1 EPS Expectations

NewLink Genetics (NASDAQ: NLNK) reported Q1 EPS of $0.35, $0.94 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'